Cargando…

Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain

Brain metastasis from triple-negative breast cancer (TNBC) has continued to lack effective clinical treatments until present. However, the feature of epidermal growth factor receptor (EGFR) frequently overexpressed in TNBC offers the opportunity to employ lapatinib, a dual-tyrosine kinase inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Xu, Zheng, Xiaoyao, Pang, Xiaoyin, Pang, Zhiqing, Zhao, Jingjing, Zhang, Zheming, Jiang, Tao, Xu, Wei, Zhang, Qizhi, Jiang, Xinguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085136/ https://www.ncbi.nlm.nih.gov/pubmed/27086917 http://dx.doi.org/10.18632/oncotarget.8697

Ejemplares similares

Dual targeting micelles loaded with paclitaxel and lapatinib for combinational therapy of brain metastases from breast cancer
por: Lu, Heng, et al.
Publicado: (2022)

Co-loaded lapatinib/PAB by ferritin nanoparticles eliminated ECM-detached cluster cells via modulating EGFR in triple-negative breast cancer
por: Wu, Xinghan, et al.
Publicado: (2022)

Intracellular delivery mechanism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes
por: Pang, Zhiqing, et al.
Publicado: (2012)

Therapeutic Mechanism of Lapatinib Combined with Sulforaphane on Gastric Cancer
por: Yi, Huixing, et al.
Publicado: (2021)

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer
por: Stringer-Reasor, Erica M., et al.
Publicado: (2021)

Antigen-conjugated N-trimethylaminoethylmethacrylate Chitosan Nanoparticles Induce Strong Immune Responses After Nasal Administration
por: Liu, Qingfeng, et al.
Publicado: (2014)

Small interfering RNA delivery to the neurons near the amyloid plaques for improved treatment of Alzheimer׳s disease
por: Guo, Qian, et al.
Publicado: (2019)

High Potency of SN-38-Loaded Bovine Serum Albumin Nanoparticles Against Triple-Negative Breast Cancer
por: Lin, Hsin-Che, et al.
Publicado: (2019)

Evaluation of Lapatinib-Loaded Microfibers Prepared by Centrifugal Spinning
por: Bitay, Enikő, et al.
Publicado: (2022)

Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
por: Chen, Yun-Ju, et al.
Publicado: (2013)

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
por: Simiczyjew, Aleksandra, et al.
Publicado: (2018)

A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib
por: Ebelt, Nancy D., et al.
Publicado: (2017)

Oncolytic viruses for triple negative breast cancer and beyond
por: Jin, Shengye, et al.
Publicado: (2021)

Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells
por: Yurt, Fatma, et al.
Publicado: (2023)

Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation
por: Huo, Zhi-Jun, et al.
Publicado: (2015)

Prognostic Value of Albumin/Globulin Ratio in Survival and Lymph Node Metastasis in Patients with Cancer: A Systematic Review and Meta-analysis
por: Chi, Jieshan, et al.
Publicado: (2018)

LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer
por: Lo, Pang-Kuo, et al.
Publicado: (2018)

Case report: Secondary sclerosing cholangitis induced by lapatinib and vinorelbine in a metastasis breast cancer patient
por: Zhang, Zhuo, et al.
Publicado: (2021)

Hypoxia-Mediated Complement 1q Binding Protein Regulates Metastasis and Chemoresistance in Triple-Negative Breast Cancer and Modulates the PKC-NF-κB-VCAM-1 Signaling Pathway
por: Wu, Hao, et al.
Publicado: (2021)

Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors
por: Widatalla, Sarrah E, et al.
Publicado: (2019)

Local delivery of minocycline-loaded PEG-PLA nanoparticles for the enhanced treatment of periodontitis in dogs
por: Yao, Wenxin, et al.
Publicado: (2014)

Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer
por: Wang, Jianguo, et al.
Publicado: (2022)

Lapatinib-Loaded Nanocapsules Enhances Antitumoral Effect in Human Bladder Cancer Cell
por: Buss, Julieti Huch, et al.
Publicado: (2019)

Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells
por: Liu, Chun-Yu, et al.
Publicado: (2016)

Human induced pluripotent stem cell-derived platelets loaded with lapatinib effectively target HER2+ breast cancer metastasis to the brain
por: Bhan, Arunoday, et al.
Publicado: (2021)

Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis
por: Zuo, Runan, et al.
Publicado: (2022)

Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization
por: Gao, Huile, et al.
Publicado: (2013)

CORRIGENDUM: Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization
por: Gao, Huile, et al.
Publicado: (2014)

Polyethylene glycol–polylactic acid nanoparticles modified with cysteine–arginine–glutamic acid–lysine–alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect
por: Wu, Junzhu, et al.
Publicado: (2014)

Immunomodulatory and Antitumor Effects of a Novel TLR7 Agonist Combined with Lapatinib
por: Gao, Ningning, et al.
Publicado: (2016)

Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6
por: Hsiao, Yu-Chun, et al.
Publicado: (2015)

Correction: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells
por: Liu, Chun-Yu, et al.
Publicado: (2017)

Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer
por: Wan, Zhong, et al.
Publicado: (2020)

Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy
por: Jin, Zining, et al.
Publicado: (2015)

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis
por: Mullen, McKay, et al.
Publicado: (2021)

Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
por: Ye, Min, et al.
Publicado: (2021)

Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
por: Guo, Peng, et al.
Publicado: (2019)

Lapatinib Suppresses HER2-Overexpressed Cholangiocarcinoma and Overcomes ABCB1– Mediated Gemcitabine Chemoresistance
por: Bai, Zhiqing, et al.
Publicado: (2022)

Risk factors for distant metastasis of patients with primary triple-negative breast cancer
por: Yao, Yi, et al.
Publicado: (2019)

Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid
por: Li, Jingjing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tsv17mnapq1l8eaq5vkm1bp5nb